Class Action Accusing J&J of Raising Insurance Premiums Via Opioid Crisis Dismissed



DOCUMENTS
  • Order


CAMDEN, N.J. — A New Jersey judge has dismissed a proposed class action accusing Johnson & Johnson and two of its subsidiaries of raising insurance premiums by creating and perpetuating the opioid crisis, ruling that the complaint failed to adequately allege causation.

In an Oct. 10 order, Judge Steven J. Polansky of the Camden County Superior Court found the plaintiff failed to specify how the actions of J&J, Janssen Pharmaceuticals, Actavis Pharma Inc. and Actavis LLC caused him and the proposed class to pay more for health insurance.

The judge explained that it is “inherently problematic” and “highly impracticable” …






UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: Surgical Stapler Litigation

January 14, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin's Webinar Series: Midwest Asbestos Litigation

December 02, 2020 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS